Spesolimab Clears Lesions in Generalized Pustular Psoriasis
In phase 2 trial, spesolimab cleared more lesions than placebo, but it was associated with infections, systemic drug reactions
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.